Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acid Supplementation vs Whey Protein in Parkinson's Disease
NCT06954662Phase 1Completed
- Sponsor
- UConn Health
- Start
- May 2025
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (3 arms), sponsored by UConn Health. Primary endpoints: Circulating levodopa concentrations at Week 4 and Circulating amino acids concentrations at Week 4. Started May 2025; status: completed.
Beyond the preview
Go deeper on NCT06954662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06954662.